Corpus
PascalFrancis
Racine
Corpus
Checkpoint
PascalFrancis
Racine
PascalFrancis
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Milestones in Research on Neurotoxins and Neuroprotection: A Tribute to Professor Toshiharu Nagatsu

Identifieur interne : 001024 ( PascalFrancis/Corpus ); précédent : 001023; suivant : 001025

Milestones in Research on Neurotoxins and Neuroprotection: A Tribute to Professor Toshiharu Nagatsu

Auteurs :

Source :

RBID : Pascal:03-0018070

Descripteurs français

English descriptors

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0892-0362
A02 01      @0 NETEEC
A03   1    @0 Neurotoxicol. teratol.
A05       @2 24
A06       @2 5
A09 01  1  ENG  @1 Milestones in Research on Neurotoxins and Neuroprotection: A Tribute to Professor Toshiharu Nagatsu
A12 01  1    @1 NAOI (Makoto) @9 ed.
A12 02  1    @1 PARVEZ (Hasan) @9 ed.
A12 03  1    @1 MARUYAMA (Wakako) @9 ed.
A12 04  1    @1 COLLINS (Michel A.) @9 ed.
A12 05  1    @1 YOUDIM (Moussa B. H.) @9 ed.
A15 01      @1 Department of Brain Sciences, Institute of Applied Biochemistry, Yagi Memorial Park @2 Mitake, Gifu 505-0116 @3 JPN @Z 1 aut.
A15 02      @1 Unit of Neuroendocrinology, Bat. 5, Parc Chateau, CNRS @2 91190 Gif sur Yvette @3 FRA @Z 2 aut.
A15 03      @1 Laboratory of Biochemistry and Metabolism, Department of Basic Gerontology, National Institute of Longevity Sciences @2 Obu, Aichi 474-8622 @3 JPN @Z 3 aut.
A15 04      @1 Department of Molecular and Cellular Biochemistry, Loyola University of Chicago, Strich School of Medicine @2 Maywood, IL 60153 @3 USA @Z 4 aut.
A15 05      @1 Eve Topf and National Parkinson Foundation Neurodegenerative Diseases Centers, Department of Pharmacology, Rappaport Faculty of Medicine, Technion @2 Haifa 31096 @3 ISR @Z 5 aut.
A21       @1 2002
A23 01      @0 ENG
A29       @1 148 p.
A43 01      @1 INIST @2 18910 @5 354000109244300000
A44       @0 0000 @1 © 2003 INIST-CNRS. All rights reserved.
A45       @0 dissem.
A47 01  1    @0 03-0018070
A60       @1 P @2 C
A61       @0 M
A64 01  1    @0 Neurotoxicology and teratology
A66 01      @0 USA
C02 01  X    @0 002B02B10
C02 02  X    @0 002B17G
C03 01  X  FRE  @0 Neurotoxine @5 01
C03 01  X  ENG  @0 Neurotoxin @5 01
C03 01  X  SPA  @0 Neurotoxina @5 01
C03 02  X  FRE  @0 Neuroprotecteur @5 04
C03 02  X  ENG  @0 Neuroprotective agent @5 04
C03 02  X  SPA  @0 Neuroprotector @5 04
C03 03  X  FRE  @0 Parkinson maladie @5 10
C03 03  X  ENG  @0 Parkinson disease @5 10
C03 03  X  SPA  @0 Parkinson enfermedad @5 10
C03 04  X  FRE  @0 Pathologie expérimentale @5 13
C03 04  X  ENG  @0 Experimental disease @5 13
C03 04  X  SPA  @0 Patología experimental @5 13
C03 05  X  FRE  @0 Animal @5 14
C03 05  X  ENG  @0 Animal @5 14
C03 05  X  SPA  @0 Animal @5 14
C03 06  X  FRE  @0 Homme @5 15
C03 06  X  ENG  @0 Human @5 15
C03 06  X  SPA  @0 Hombre @5 15
C03 07  X  FRE  @0 Congrès @5 16
C03 07  X  ENG  @0 Congress @5 16
C03 07  X  SPA  @0 Congreso @5 16
C03 08  X  FRE  @0 Pathogénie @5 17
C03 08  X  ENG  @0 Pathogenesis @5 17
C03 08  X  SPA  @0 Patogenia @5 17
C07 01  X  FRE  @0 Toxine
C07 01  X  ENG  @0 Toxin
C07 01  X  SPA  @0 Toxina
C07 02  X  FRE  @0 Système nerveux pathologie @5 61
C07 02  X  ENG  @0 Nervous system diseases @5 61
C07 02  X  SPA  @0 Sistema nervioso patología @5 61
C07 03  X  FRE  @0 Système nerveux central pathologie @5 62
C07 03  X  ENG  @0 Central nervous system disease @5 62
C07 03  X  SPA  @0 Sistema nervosio central patología @5 62
C07 04  X  FRE  @0 Encéphale pathologie @5 63
C07 04  X  ENG  @0 Cerebral disorder @5 63
C07 04  X  SPA  @0 Encéfalo patología @5 63
C07 05  X  FRE  @0 Extrapyramidal syndrome @5 64
C07 05  X  ENG  @0 Extrapyramidal syndrome @5 64
C07 05  X  SPA  @0 Extrapiramidal síndrome @5 64
C07 06  X  FRE  @0 Maladie dégénérative @5 65
C07 06  X  ENG  @0 Degenerative disease @5 65
C07 06  X  SPA  @0 Enfermedad degenerativa @5 65
N21       @1 006
N82       @1 PSI
pR  
A30 01  1  ENG  @1 International Catecholamine Symposium @2 9 @3 Kyoto JPN @4 2001-03-31
A30 02  1  ENG  @1 International Joint Congresses on Progress in Alzheimer's and Parkinson's Disease @2 5 @3 Kyoto JPN @4 2001-03-31

Format Inist (serveur)

NO : PASCAL 03-0018070 INIST
ET : Milestones in Research on Neurotoxins and Neuroprotection: A Tribute to Professor Toshiharu Nagatsu
AU : NAOI (Makoto); PARVEZ (Hasan); MARUYAMA (Wakako); COLLINS (Michel A.); YOUDIM (Moussa B. H.)
AF : Department of Brain Sciences, Institute of Applied Biochemistry, Yagi Memorial Park/Mitake, Gifu 505-0116/Japon (1 aut.); Unit of Neuroendocrinology, Bat. 5, Parc Chateau, CNRS/91190 Gif sur Yvette/France (2 aut.); Laboratory of Biochemistry and Metabolism, Department of Basic Gerontology, National Institute of Longevity Sciences/Obu, Aichi 474-8622/Japon (3 aut.); Department of Molecular and Cellular Biochemistry, Loyola University of Chicago, Strich School of Medicine/Maywood, IL 60153/Etats-Unis (4 aut.); Eve Topf and National Parkinson Foundation Neurodegenerative Diseases Centers, Department of Pharmacology, Rappaport Faculty of Medicine, Technion/Haifa 31096/Israël (5 aut.)
DT : Publication en série; Congrès; Niveau monographique
SO : Neurotoxicology and teratology; ISSN 0892-0362; Coden NETEEC; Etats-Unis; Da. 2002; Vol. 24; No. 5; ; Pp. 148 p.; Bibl. dissem.
LA : Anglais
CC : 002B02B10; 002B17G
FD : Neurotoxine; Neuroprotecteur; Parkinson maladie; Pathologie expérimentale; Animal; Homme; Congrès; Pathogénie
FG : Toxine; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative
ED : Neurotoxin; Neuroprotective agent; Parkinson disease; Experimental disease; Animal; Human; Congress; Pathogenesis
EG : Toxin; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease
SD : Neurotoxina; Neuroprotector; Parkinson enfermedad; Patología experimental; Animal; Hombre; Congreso; Patogenia
LO : INIST-18910.354000109244300000
ID : 03-0018070

Links to Exploration step

Pascal:03-0018070

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="m">Milestones in Research on Neurotoxins and Neuroprotection: A Tribute to Professor Toshiharu Nagatsu</title>
<author>
<name sortKey="Naoi, Makoto" sort="Naoi, Makoto" uniqKey="Naoi M" first="Makoto" last="Naoi">Makoto Naoi</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Brain Sciences, Institute of Applied Biochemistry, Yagi Memorial Park</s1>
<s2>Mitake, Gifu 505-0116</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Parvez, Hasan" sort="Parvez, Hasan" uniqKey="Parvez H" first="Hasan" last="Parvez">Hasan Parvez</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Unit of Neuroendocrinology, Bat. 5, Parc Chateau, CNRS</s1>
<s2>91190 Gif sur Yvette</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Maruyama, Wakako" sort="Maruyama, Wakako" uniqKey="Maruyama W" first="Wakako" last="Maruyama">Wakako Maruyama</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Laboratory of Biochemistry and Metabolism, Department of Basic Gerontology, National Institute of Longevity Sciences</s1>
<s2>Obu, Aichi 474-8622</s2>
<s3>JPN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Collins, Michel A" sort="Collins, Michel A" uniqKey="Collins M" first="Michel A." last="Collins">Michel A. Collins</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Department of Molecular and Cellular Biochemistry, Loyola University of Chicago, Strich School of Medicine</s1>
<s2>Maywood, IL 60153</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Youdim, Moussa B H" sort="Youdim, Moussa B H" uniqKey="Youdim M" first="Moussa B. H." last="Youdim">Moussa B. H. Youdim</name>
<affiliation>
<inist:fA14 i1="05">
<s1>Eve Topf and National Parkinson Foundation Neurodegenerative Diseases Centers, Department of Pharmacology, Rappaport Faculty of Medicine, Technion</s1>
<s2>Haifa 31096</s2>
<s3>ISR</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">03-0018070</idno>
<date when="2002">2002</date>
<idno type="stanalyst">PASCAL 03-0018070 INIST</idno>
<idno type="RBID">Pascal:03-0018070</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001024</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic></analytic>
<series>
<title level="j" type="main">Neurotoxicology and teratology</title>
<title level="j" type="abbreviated">Neurotoxicol. teratol.</title>
<idno type="ISSN">0892-0362</idno>
<imprint>
<date when="2002">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Neurotoxicology and teratology</title>
<title level="j" type="abbreviated">Neurotoxicol. teratol.</title>
<idno type="ISSN">0892-0362</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animal</term>
<term>Congress</term>
<term>Experimental disease</term>
<term>Human</term>
<term>Neuroprotective agent</term>
<term>Neurotoxin</term>
<term>Parkinson disease</term>
<term>Pathogenesis</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Neurotoxine</term>
<term>Neuroprotecteur</term>
<term>Parkinson maladie</term>
<term>Pathologie expérimentale</term>
<term>Animal</term>
<term>Homme</term>
<term>Congrès</term>
<term>Pathogénie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0892-0362</s0>
</fA01>
<fA02 i1="01">
<s0>NETEEC</s0>
</fA02>
<fA03 i2="1">
<s0>Neurotoxicol. teratol.</s0>
</fA03>
<fA05>
<s2>24</s2>
</fA05>
<fA06>
<s2>5</s2>
</fA06>
<fA09 i1="01" i2="1" l="ENG">
<s1>Milestones in Research on Neurotoxins and Neuroprotection: A Tribute to Professor Toshiharu Nagatsu</s1>
</fA09>
<fA12 i1="01" i2="1">
<s1>NAOI (Makoto)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1">
<s1>PARVEZ (Hasan)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="03" i2="1">
<s1>MARUYAMA (Wakako)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="04" i2="1">
<s1>COLLINS (Michel A.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="05" i2="1">
<s1>YOUDIM (Moussa B. H.)</s1>
<s9>ed.</s9>
</fA12>
<fA15 i1="01">
<s1>Department of Brain Sciences, Institute of Applied Biochemistry, Yagi Memorial Park</s1>
<s2>Mitake, Gifu 505-0116</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA15 i1="02">
<s1>Unit of Neuroendocrinology, Bat. 5, Parc Chateau, CNRS</s1>
<s2>91190 Gif sur Yvette</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA15>
<fA15 i1="03">
<s1>Laboratory of Biochemistry and Metabolism, Department of Basic Gerontology, National Institute of Longevity Sciences</s1>
<s2>Obu, Aichi 474-8622</s2>
<s3>JPN</s3>
<sZ>3 aut.</sZ>
</fA15>
<fA15 i1="04">
<s1>Department of Molecular and Cellular Biochemistry, Loyola University of Chicago, Strich School of Medicine</s1>
<s2>Maywood, IL 60153</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA15>
<fA15 i1="05">
<s1>Eve Topf and National Parkinson Foundation Neurodegenerative Diseases Centers, Department of Pharmacology, Rappaport Faculty of Medicine, Technion</s1>
<s2>Haifa 31096</s2>
<s3>ISR</s3>
<sZ>5 aut.</sZ>
</fA15>
<fA21>
<s1>2002</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA29>
<s1>148 p.</s1>
</fA29>
<fA43 i1="01">
<s1>INIST</s1>
<s2>18910</s2>
<s5>354000109244300000</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2003 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>dissem.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>03-0018070</s0>
</fA47>
<fA60>
<s1>P</s1>
<s2>C</s2>
</fA60>
<fA61>
<s0>M</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Neurotoxicology and teratology</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X">
<s0>002B02B10</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Neurotoxine</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Neurotoxin</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Neurotoxina</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Neuroprotecteur</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Neuroprotective agent</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Neuroprotector</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Parkinson maladie</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Pathologie expérimentale</s0>
<s5>13</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Experimental disease</s0>
<s5>13</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Patología experimental</s0>
<s5>13</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Animal</s0>
<s5>14</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Animal</s0>
<s5>14</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Animal</s0>
<s5>14</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Homme</s0>
<s5>15</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Human</s0>
<s5>15</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>15</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Congrès</s0>
<s5>16</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Congress</s0>
<s5>16</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Congreso</s0>
<s5>16</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Pathogénie</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Pathogenesis</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Patogenia</s0>
<s5>17</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Toxine</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Toxin</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Toxina</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>61</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>61</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>61</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>62</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>62</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>62</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>63</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>63</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>63</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>64</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>64</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>64</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>65</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>65</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>65</s5>
</fC07>
<fN21>
<s1>006</s1>
</fN21>
<fN82>
<s1>PSI</s1>
</fN82>
</pA>
<pR>
<fA30 i1="01" i2="1" l="ENG">
<s1>International Catecholamine Symposium</s1>
<s2>9</s2>
<s3>Kyoto JPN</s3>
<s4>2001-03-31</s4>
</fA30>
<fA30 i1="02" i2="1" l="ENG">
<s1>International Joint Congresses on Progress in Alzheimer's and Parkinson's Disease</s1>
<s2>5</s2>
<s3>Kyoto JPN</s3>
<s4>2001-03-31</s4>
</fA30>
</pR>
</standard>
<server>
<NO>PASCAL 03-0018070 INIST</NO>
<ET>Milestones in Research on Neurotoxins and Neuroprotection: A Tribute to Professor Toshiharu Nagatsu</ET>
<AU>NAOI (Makoto); PARVEZ (Hasan); MARUYAMA (Wakako); COLLINS (Michel A.); YOUDIM (Moussa B. H.)</AU>
<AF>Department of Brain Sciences, Institute of Applied Biochemistry, Yagi Memorial Park/Mitake, Gifu 505-0116/Japon (1 aut.); Unit of Neuroendocrinology, Bat. 5, Parc Chateau, CNRS/91190 Gif sur Yvette/France (2 aut.); Laboratory of Biochemistry and Metabolism, Department of Basic Gerontology, National Institute of Longevity Sciences/Obu, Aichi 474-8622/Japon (3 aut.); Department of Molecular and Cellular Biochemistry, Loyola University of Chicago, Strich School of Medicine/Maywood, IL 60153/Etats-Unis (4 aut.); Eve Topf and National Parkinson Foundation Neurodegenerative Diseases Centers, Department of Pharmacology, Rappaport Faculty of Medicine, Technion/Haifa 31096/Israël (5 aut.)</AF>
<DT>Publication en série; Congrès; Niveau monographique</DT>
<SO>Neurotoxicology and teratology; ISSN 0892-0362; Coden NETEEC; Etats-Unis; Da. 2002; Vol. 24; No. 5; ; Pp. 148 p.; Bibl. dissem.</SO>
<LA>Anglais</LA>
<CC>002B02B10; 002B17G</CC>
<FD>Neurotoxine; Neuroprotecteur; Parkinson maladie; Pathologie expérimentale; Animal; Homme; Congrès; Pathogénie</FD>
<FG>Toxine; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative</FG>
<ED>Neurotoxin; Neuroprotective agent; Parkinson disease; Experimental disease; Animal; Human; Congress; Pathogenesis</ED>
<EG>Toxin; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease</EG>
<SD>Neurotoxina; Neuroprotector; Parkinson enfermedad; Patología experimental; Animal; Hombre; Congreso; Patogenia</SD>
<LO>INIST-18910.354000109244300000</LO>
<ID>03-0018070</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001024 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001024 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:03-0018070
   |texte=   Milestones in Research on Neurotoxins and Neuroprotection: A Tribute to Professor Toshiharu Nagatsu
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024